期刊文献+

红景天、蛹虫草、大黄配伍治疗代谢综合征的实验研究Ⅱ——治疗肥胖症作用 被引量:9

Investigation of a compound,compatibility of Rhodiola crenulata, Cordyceps militaris,and Rheum palmatum,on metabolic syndrome treatment Ⅱ——improving obesity
原文传递
导出
摘要 利用高脂饮食诱导的胰岛素抵抗的IRF肥胖小鼠和2型糖尿病KKAy肥胖小鼠模型,观察红景天、蛹虫草、大黄配伍组成的中药复方FF16治疗肥胖症作用并初步探讨其作用机制。结果显示,FF16显著控制IRF小鼠和KKAy小鼠的体重增长;改善KKAy小鼠高TC血症和高TG血症;降低IRF小鼠的血清TC水平、增加血清HDL-C含量、减小脂肪指数。体外酶学实验显示,FF16可明显抑制分子靶点α-葡萄糖苷酶的活性。说明中药组方FF16具有明显降低肥胖小鼠体重、调节脂代谢紊乱等治疗肥胖症的作用,抑制α-葡萄糖苷酶是其作用机制之一。 To investigate the effect of compound FF16, compatibility of Rhodiola crenulata, Cordyceps militaris, and Rheum pal matum, on obesity, both the insulin resistant obese IRF mouse model induced by high fat diet and the spontaneous type 2 diabetes KKAy obese mouse model were used. The results showed that the body weights and the energy uptake were markedly reduced by com- pound FF16 in both IRF mice in dose-dependent manner and KKAy mice, respectively. Meanwhile, with the administration of FF16, the hypercholesterolemia and the hypertriglyceridemia were improved significantly in KKAy mice; and the levels of serum cholesterol and fatty index were decreased obviously, and the value of serum HDL-C was increased significantly in IRF mice, respectively. Moreo- ver, the activity of α-glycosidase was inhibited by compound FF16 in vitro. In conclusion, FF16 could improve the obesity by inhibiting α-glycosidase activity.
出处 《中国中药杂志》 CAS CSCD 北大核心 2013年第9期1411-1415,共5页 China Journal of Chinese Materia Medica
基金 科技部“重大新药创制”科技重大专项(2009ZX09103-432,2012ZX09103101-063,2012ZX09301002-004,2013LCQ-07)
关键词 中药复方FF16 肥胖症 IRF小鼠 KKAY小鼠 Α-葡萄糖苷酶 traditional Chinese medicine compound FF16 obesity IRF mice KKAy mice α-glycosidase
  • 相关文献

参考文献12

  • 1Simon Schenk, Maziyar Sabefi, Jerrold M Olefsky. Insulin sensi- tivity: modulation by nutrients and inflammation [ J ]. J Clin In- vest, 2008, 118(9) :2992.
  • 2Wei-Na Cong, Rong-Ya Tao, Jin-ying Tian, et al. The establish- ment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice[ J]. Life Sci, 2008, 82 : 983.
  • 3Scott M Grundy. Drug therapy of the metabolic syndrome: mini- mizing the emerging crisis in polypharmacy[ J]. Nature Review, 2006, 5:295.
  • 4祝之明.代谢综合征:一种肥胖相关的代谢性心血管综合征[J].中华内分泌代谢杂志,2007,23(4):291-293. 被引量:29
  • 5刘金晖,卢耀勤.红景天提取物降脂作用的实验研究[J].新疆中医药,2010,28(3):7-9. 被引量:3
  • 6刘苏萌,王丽娟,司艳红,何培新.蛹虫草基质粗多糖提取及抗氧化活性测定[J].食品科技,2009,34(7):179-181. 被引量:10
  • 7李晓红,李蒙,陶艳蓉.大黄酸及其衍生物药理作用研究新进展[J].现代药物与临床,2010,25(6):417-421. 被引量:50
  • 8Rongya Tao, Fei Ye, Yibo He,et al. Improvement of high-fat-di- et-induced metabolic syndrome by a compound from Balanophora polyandra Griff in mice[J]. Euro J Phannacol,2009,616: 328.
  • 9李婷,张小东,宋聿文,等.一种用微孔板筛选alpha一葡萄糖苷酶抑制剂的方法[J].中国l临床药理学与治疗学,2005,10(10):1128.
  • 10Arion J Kennedy. Mouse models of the metabolic syndrome [ J]. Dis Model Mech,2010, 3(3/4) :156.

二级参考文献96

共引文献98

同被引文献152

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部